These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 32495862)

  • 1. MicroRNA-18a suppresses ovarian carcinoma progression by targeting CBX7 and regulating ERK/MAPK signaling pathway and epithelial-to-mesenchymal transition.
    Zhao Y; Liu XL; Huang JH; Yin AJ; Zhang H
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5292-5302. PubMed ID: 32495862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-489 targets XIAP to inhibit the biological progression of ovarian cancer via regulating PI3K/Akt signaling pathway and epithelial-to-mesenchymal transition.
    Jiang HW; Li L; Jiang P; Wang YF
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4113-4122. PubMed ID: 32373947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-149 suppresses the malignant phenotypes of ovarian cancer via downregulation of MSI2 and inhibition of PI3K/AKT pathway.
    Zhao LW; Yu AJ; Zhang YJ; Wang XC; Han B; Wang XH
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):55-64. PubMed ID: 31957818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-486 inhibits cell proliferation, invasion and migration via down-regulating the TENM1 expressions and affecting ERK and Akt signaling pathways and epithelial-to-mesenchymal transition in papillary thyroid carcinoma.
    Sun YH; Liu ZF; Yang BB; Yu B
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8429-8439. PubMed ID: 31646573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-31 inhibits papillary thyroid carcinoma cell biological progression by directly targeting SOX11 and regulating epithelial-to-mesenchymal transition, ERK and Akt signaling pathways.
    Wang Y; Liu BG; Zhou CX
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5863-5873. PubMed ID: 31298337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-508 suppresses epithelial-mesenchymal transition, migration, and invasion of ovarian cancer cells through the MAPK1/ERK signaling pathway.
    Hong L; Wang Y; Chen W; Yang S
    J Cell Biochem; 2018 Sep; 119(9):7431-7440. PubMed ID: 29781537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-23b suppresses cervical cancer biological progression by directly targeting six1 and affecting epithelial-to-mesenchymal transition and AKT/mTOR signaling pathway.
    Li YM; Li XJ; Yang HL; Zhang YB; Li JC
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4688-4697. PubMed ID: 31210295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-18a-5p Promotes Proliferation and Migration of Vascular Smooth Muscle Cells by Activating the AKT/Extracellular Regulated Protein Kinases (ERK) Signaling Pathway.
    Zhang Y; Chen X
    Med Sci Monit; 2020 May; 26():e924625. PubMed ID: 32458821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-760 inhibits the biological progression of colorectal carcinoma by directly targeting FOXA1 and regulating epithelial-to-mesenchymal transition and PI3K/AKT signaling pathway.
    Cong K; Li CG; Wei YH; Zhang K; Xu HB
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5730-5740. PubMed ID: 31298352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-22 targets FMNL2 to inhibit melanoma progression via the regulation of the Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition.
    Shi L; Huo JW; Chen SS; Xue JX; Gao WY; Li XY; Song YH; Xu HT; Zhu XW; Chen K
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5332-5342. PubMed ID: 31298385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-218 regulates the epithelial-to-mesenchymal transition and the PI3K/Akt signaling pathway to suppress lung adenocarcinoma progression by directly targeting BMI-1.
    Xu L; Sun HB; Xu ZN; Han XL; Yin YY; Zheng Y; Zhao Y; Wang ZX
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7978-7988. PubMed ID: 31599423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA WDFY3-AS2 suppresses tumor progression by acting as a competing endogenous RNA of microRNA-18a in ovarian cancer.
    Li W; Ma S; Bai X; Pan W; Ai L; Tan W
    J Cell Physiol; 2020 Feb; 235(2):1141-1154. PubMed ID: 31347170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lncRNA SNHG15/miR-18a-5p axis promotes cell proliferation in ovarian cancer through activating Akt/mTOR signaling pathway.
    Zhang J; Wang L; Jiang J; Qiao Z
    J Cell Biochem; 2020 Dec; 121(12):4699-4710. PubMed ID: 33135285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-296 functions as a tumor suppressor in breast cancer by targeting FGFR1 and regulating the Wnt/β-catenin signaling pathway.
    Sun WM; Tao W; Li JC; Zhu DM; Miao Y
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10422-10432. PubMed ID: 31841196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
    He Y; He X
    Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting EZH2 by microRNA-449a inhibits osteosarcoma cell proliferation, invasion and migration via regulation of PI3K/AKT signaling pathway and epithelial-mesenchymal transition.
    Lu DG; Tang QL; Wei JH; He FY; Lu L; Tang YJ
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1656-1665. PubMed ID: 32141531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-181c Suppresses the Biological Progression of Osteosarcoma via Targeting SMAD7 and Regulating Transforming Growth Factor-β (TGF-β) Signaling Pathway.
    Fu Y; Tang Y; Wang J; Guo Z
    Med Sci Monit; 2019 Jun; 25():4801-4810. PubMed ID: 31251735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-15 suppressed the progression of bladder cancer by targeting BMI1 oncogene via PI3K/AKT signaling pathway.
    Zhang L; Wang CZ; Ma M; Shao GF
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8813-8822. PubMed ID: 31696468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-18a-5p derived from mesenchymal stem cells-extracellular vesicles inhibits ovarian cancer cell proliferation, migration, invasion, and chemotherapy resistance.
    Wang X; Jiang L; Liu Q
    J Transl Med; 2022 Jun; 20(1):258. PubMed ID: 35672774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
    Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
    Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.